Progress in The Research of Lactate Metabolism Disruption And Astrocyte-Neuron Lactate Shuttle Impairment in Schizophrenia : A Comprehensive Review
© 2024 Wiley‐VCH GmbH..
Schizophrenia (SCZ) is a complex neuropsychiatric disorder widely recognized for its impaired bioenergy utilization. The astrocyte-neuron lactate shuttle (ANLS) plays a critical role in brain energy supply. Recent studies have revealed abnormal lactate metabolism in SCZ, which is associated with mitochondrial dysfunction, tissue hypoxia, gastric acid retention, oxidative stress, neuroinflammation, abnormal brain iron metabolism, cerebral white matter hypermetabolic activity, and genetic susceptibility. Furthermore, astrocytes, neurons, and glutamate abnormalities are prevalent in SCZ with abnormal lactate metabolism, which are essential components for maintaining ANLS in the brain. Therefore, an in-depth study of the pathophysiological mechanisms of ANLS in SCZ with abnormal lactate metabolism will contribute to a better understanding of the pathogenesis of SCZ and provide new ideas and approaches for the diagnosis and treatment of SCZ.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Advanced biology - (2024) vom: 10. Apr., Seite e2300409 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Yingying [VerfasserIn] |
---|
Links: |
---|
Themen: |
Astrocyte‐neuron lactate shuttle (ANLS) |
---|
Anmerkungen: |
Date Revised 10.04.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1002/adbi.202300409 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370861787 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM370861787 | ||
003 | DE-627 | ||
005 | 20240410233532.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240410s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/adbi.202300409 |2 doi | |
028 | 5 | 2 | |a pubmed24n1371.xml |
035 | |a (DE-627)NLM370861787 | ||
035 | |a (NLM)38596839 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Yingying |e verfasserin |4 aut | |
245 | 1 | 0 | |a Progress in The Research of Lactate Metabolism Disruption And Astrocyte-Neuron Lactate Shuttle Impairment in Schizophrenia |b A Comprehensive Review |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 10.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a © 2024 Wiley‐VCH GmbH. | ||
520 | |a Schizophrenia (SCZ) is a complex neuropsychiatric disorder widely recognized for its impaired bioenergy utilization. The astrocyte-neuron lactate shuttle (ANLS) plays a critical role in brain energy supply. Recent studies have revealed abnormal lactate metabolism in SCZ, which is associated with mitochondrial dysfunction, tissue hypoxia, gastric acid retention, oxidative stress, neuroinflammation, abnormal brain iron metabolism, cerebral white matter hypermetabolic activity, and genetic susceptibility. Furthermore, astrocytes, neurons, and glutamate abnormalities are prevalent in SCZ with abnormal lactate metabolism, which are essential components for maintaining ANLS in the brain. Therefore, an in-depth study of the pathophysiological mechanisms of ANLS in SCZ with abnormal lactate metabolism will contribute to a better understanding of the pathogenesis of SCZ and provide new ideas and approaches for the diagnosis and treatment of SCZ | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a astrocyte‐neuron lactate shuttle (ANLS) | |
650 | 4 | |a glutamate | |
650 | 4 | |a l‐lactate | |
650 | 4 | |a schizophrenia (SCZ) | |
700 | 1 | |a Tong, Liang |e verfasserin |4 aut | |
700 | 1 | |a Ma, Li |e verfasserin |4 aut | |
700 | 1 | |a Ye, Hong |e verfasserin |4 aut | |
700 | 1 | |a Zeng, Shue |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Shaochuan |e verfasserin |4 aut | |
700 | 1 | |a Ding, Yu |e verfasserin |4 aut | |
700 | 1 | |a Wang, Weiwei |e verfasserin |4 aut | |
700 | 1 | |a Bao, Tianhao |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Advanced biology |d 2021 |g (2024) vom: 10. Apr., Seite e2300409 |w (DE-627)NLM314964096 |x 2701-0198 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:10 |g month:04 |g pages:e2300409 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/adbi.202300409 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 10 |c 04 |h e2300409 |